MetaTrader
  • 市场
  • 图表与思路
  • Algo
  • 新闻
  • Store
  • 经纪商
  • 下载
  • 经济日历
  • 交易信号
  • 网页端
  • English English
  • Русский Русский
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

KNSA

#1371
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
44.4900
+2.82%
版块:
基础:
利润货币:
日范围
44.4900
44.4900
年范围
35.2000
49.1200
日变化
+2.82%
每月变动
-1.13%
6个月变化
+12.22%
年变化
+12.22%
前一天收盘价
43.2700
Open
44.4900
Bid
Ask
Low
44.4900
High
44.4900
交易量
71
  1. 市场
  2. 股票
  3. 医疗保健
  4. KNSA
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

新闻

Investor's Business Daily Investor's Business Daily
KNSA AUPH HROW ARQT FNV
昨天, 00:08
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Investor's Business Daily Investor's Business Daily
ASML NVT KEYS HUT MSFT
前天, 00:11
ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens
Investor's Business Daily Investor's Business Daily
NRIX INVA KNSA ARGX
2026.02.25
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Investor's Business Daily Investor's Business Daily
ROAD FNV AEM EQX TARS
2026.02.24
Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders
Investing Investing
KNSA
2026.02.24
Kiniksa Pharma Q4 每股收益 逊于预期, 营收 超出预期
Investing Investing
KNSA
2026.02.24
Kiniksa Pharma earnings missed by $0.18, revenue topped estimates
Investing Investing
KNSA
2026.02.24
Wedbush上调Kiniksa目标价至53美元,看好新药上市前景
Investing Investing
KNSA
2026.02.24
Wedbush raises Kiniksa stock price target to $53 on launch outlook
Seeking Alpha Seeking Alpha
KNSA
2026.02.24
Kiniksa Pharmaceuticals International, plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-02-24
Investing Investing
KNSA
2026.02.24
Kiniksa Q4 2025 slides: ARCALYST drives 62% growth, profitability
Investing Investing
KNSA
2026.02.23
Kiniksa财报备受关注,罕见病药物推动增长
Investing Investing
KNSA
2026.02.23
Kiniksa earnings in focus as rare disease drug fuels growth

市场

  • 股票
  • 货币
  • 数字加密货币
  • 金属
  • 大宗商品

图表与思路

  • 交易理念
  • 教育理念
  • 图表

MQL5 社区

  • 市场
  • 信号
  • 论坛
  • 文章
  • 代码库

新闻

  • 股票
  • 货币
  • 数字加密货币
  • 金属
  • 大宗商品

经纪商

  • 所有经纪商
  • 外汇
  • 股票
  • 金属
MetaTrader 5
MQL5 Channels
Economic Calendar
免责声明及风险披露 使用条款 联系和请求 法律
Copyright 2000-2026, MetaQuotes Ltd